Continuing Enhanced National Surveillance for Prion Diseases in the United States
Forecasted Federal grant Posted
- Opportunity number
- CDC-RFA-CK-27-0046
- Agency
-
Centers for Disease Control and Prevention
Department of Health and Human Services
- Applications expected due
- Award size
- $3,000,000 to $25,000,000
Opportunity facts
- Expected posting
- Assistance listings
-
- 93.317 Emerging Infections Programs
- Funding instrument
- Cooperative Agreement
- Category
-
- Health
- Eligible applicants
-
- Small Businesses
- Tribal Organizations (Not Federally Recognized)
- For Profit Organizations
- State Governments
- Non-501(c)(3) Nonprofits
- County Governments
- Tribal Governments (Federally Recognized)
- Independent School Districts
- Higher Education Inst. (Public)
- City/Township Governments
- Higher Education Inst. (Private)
- Unrestricted
- Special District Governments
- 501(c)(3) Nonprofits
- Points of contact
-
- Lisa Angel langel@cdc.gov (404) 639-1083
Opportunity details come from Grants.gov. Updated .
About this opportunity
The Centers for Disease Control and Prevention is forecasting FY 2027 cooperative agreement funding to continue enhanced national surveillance for human prion diseases (transmissible spongiform encephalopathies) in the United States, with no application deadline specified in this forecast notice.
Eligible applicants are unrestricted and include small businesses, tribal organizations (federally and non-federally recognized), for-profit organizations, state and county governments, city and township governments, special district governments, independent school districts, 501(c)(3) nonprofits, non-501(c)(3) nonprofits, and both public and private higher education institutions.
The program funds a specialized diagnostic center to conduct state-of-the-art prion disease diagnostic techniques and confirm suspected and clinically diagnosed cases of human prion disease. Since 1997, CDC has funded such a center to provide diagnostic services, enabling disease confirmation, evaluation of disease trends, identification of disease subtypes, and monitoring for emerging prion diseases including potential human cases of chronic wasting disease. The center collaborates with CDC experts who provide guidance and epidemiological knowledge to inform national surveillance findings.
Activities fall under the parent Emerging Infections Programs (CFDA 93.317), which supports active surveillance, applied epidemiologic and laboratory activities, pilot prevention and intervention projects, and rapid response to emerging infectious disease threats. Awards are issued for 12-month budget periods within a project period of up to five years, subject to satisfactory progress and available funding. Allowable costs include personnel, travel, supplies, and contractual services supporting surveillance and laboratory infrastructure. Successful applicants are eligible for non-competitive annual continuation funding in successive budget periods. Applications are evaluated on capacity to perform core EIP functions, proposed operational plans, and effectiveness measures.
Forecast synopsis
The CDC announces the availability of FY 2027 funds for a cooperative agreement to continue enhanced national surveillance for human prion diseases, also known as transmissible spongiform encephalopathies (TSEs), in the United States. The purpose is to continue an active surveillance program to help confirm suspected and clinically diagnosed cases of human prion disease and to monitor the occurrence of potentially emerging human prion diseases in the United States. Outcomes are enhanced national surveillance for always fatal human prion diseases through improved diagnoses and continued monitoring for emerging or new prion diseases in the United States. These outcomes are accomplished through the funding of a specialized center to conduct state-of-the-art diagnostic techniques. Prion diseases can only be confirmed through brain tissue analyses, and many facilities lack the expertise and/or the willingness, due to infection control concerns, to handle and accurately diagnose specimens from suspected cases. Since 1997, the Centers for Disease Control and Prevention (CDC) has funded a center to provide prion disease diagnostic services, which has allowed for disease confirmation, evaluation of disease trends over time, and identification of disease subtypes. Data have been shared with CDC experts who partner with center staff, providing guidance and epidemiological knowledge. This collaboration has contributed to accurate national surveillance findings and helped to provide confidence that novel prion diseases, such as a human form of the animal prion disease, chronic wasting disease, have not been occurring in the country.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity